All questionsIndication: Vabysmo (faricimab-svoa), all indications3 questions · 1 sourceDrug namesWhat is the generic name of Vabysmo?“VABYSMO® (faricimab-svoa) injection, for intravitreal use” (opens the source at this quote in a new tab)CopyFlag“Faricimab-svoa is a humanized bispecific immunoglobulin G1 (IgG1) antibody that binds both vascular endothelial growth factor A (VEGF-A) and angiopoietin-2 (Ang-2).” (opens the source at this quote in a new tab)CopyFlagWho makes Vabysmo?“Manufactured by: Genentech, Inc. A Member of the Roche Group” (opens the source at this quote in a new tab)CopyFlagIndicationWhen was Vabysmo first approved by the FDA?“Initial U.S. Approval: 2022” (opens the source at this quote in a new tab)CopyFlag